InTeraSEQ Genetics

InTeraSEQ is a Houston-based biotechnology company that provides advanced immune repertoire sequencing solutions. The company's core technology, the InTeraSEQ platform, allows for the simultaneous and high-throughput profiling of T-cell and B-cell receptors with exceptional sensitivity. Originally developed at the MD Anderson Cancer Center, this technology is used to monitor immune dynamics in patients undergoing immunotherapy, aiding in the discovery of biomarkers and the development of precision medicines. InTeraSEQ offers its capabilities through both laboratory services and specialized sequencing kits for research and clinical applications. Their approach addresses the limitations of traditional NGS by providing higher accuracy and lower error rates in identifying rare immune clones.